| 1 | Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters | 3.2 | 4 | Citations (PDF) |
| 2 | Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants | 13.9 | 12 | Citations (PDF) |
| 3 | SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities | 2.2 | 1 | Citations (PDF) |
| 4 | An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings | 4.5 | 1 | Citations (PDF) |
| 5 | Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection | 5.4 | 47 | Citations (PDF) |
| 6 | A tale of two waves: characteristics and outcomes of COVID-19 admissions during the Omicron-driven fourth wave in Cape Town, South Africa, and implications for the future | 1.6 | 4 | Citations (PDF) |
| 7 | LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters | 3.3 | 5 | Citations (PDF) |
| 8 | How South Africa Used National Cycle Threshold (Ct) Values to Continuously Monitor SARS-CoV-2 Laboratory Test Quality | 3.0 | 3 | Citations (PDF) |
| 9 | Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania | 3.2 | 17 | Citations (PDF) |
| 10 | Tracking the circulating SARS-CoV-2 variant of concern in South Africa using wastewater-based epidemiology | 3.5 | 38 | Citations (PDF) |
| 11 | Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa | 38.7 | 69 | Citations (PDF) |
| 12 | Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa | 38.7 | 1,636 | Citations (PDF) |
| 13 | Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests | 1.7 | 8 | Citations (PDF) |
| 14 | Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage | 13.9 | 34 | Citations (PDF) |
| 15 | Challenges and complexities in evaluating severe acute respiratory syndrome coronavirus 2 molecular diagnostics during the COVID-19 pandemic | 0.7 | 5 | Citations (PDF) |
| 16 | Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis | 2.2 | 24 | Citations (PDF) |
| 17 | Outcomes of laboratory‐confirmed <scp>SARS‐CoV</scp>‐2 infection in the Omicron‐driven fourth wave compared with previous waves in the Western Cape Province, South Africa | 2.0 | 119 | Citations (PDF) |
| 18 | Delays in HIV-1 infant polymerase chain reaction testing may leave children without confirmed diagnoses in the Western Cape province, South Africa | 0.7 | 1 | Citations (PDF) |
| 19 | Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa | 39.5 | 617 | Citations (PDF) |
| 20 | Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. | 0.7 | 0 | Citations (PDF) |
| 21 | The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance | 36.4 | 149 | Citations (PDF) |
| 22 | From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa—Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality | 5.4 | 60 | Citations (PDF) |
| 23 | HIV false positive screening serology due to sample contamination reduced by a dedicated sample and platform in a high prevalence environment | 2.4 | 3 | Citations (PDF) |
| 24 | Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa | 2.4 | 51 | Citations (PDF) |
| 25 | Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa | 3.3 | 22 | Citations (PDF) |
| 26 | Detection of a SARS-CoV-2 variant of concern in South Africa | 38.7 | 1,609 | Citations (PDF) |
| 27 | Wastewater treatment works change the intestinal microbiomes of insectivorous bats | 2.4 | 13 | Citations (PDF) |
| 28 | Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis | 3.2 | 12 | Citations (PDF) |
| 29 | Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review | 3.1 | 17 | Citations (PDF) |
| 30 | Molecular characterisation and epidemiology of enterovirus-associated aseptic meningitis in the Western and Eastern Cape Provinces, South Africa 2018–2019 | 3.1 | 16 | Citations (PDF) |
| 31 | HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens | 15.3 | 94 | Citations (PDF) |
| 32 | Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIV | 1.8 | 6 | Citations (PDF) |
| 33 | A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa | 36.4 | 198 | Citations (PDF) |
| 34 | Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV | 2.4 | 25 | Citations (PDF) |
| 35 | Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults | 3.1 | 24 | Citations (PDF) |
| 36 | Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia | 2.4 | 3 | Citations (PDF) |
| 37 | Turnaround times – the Achilles’ heel of community screening and testing in Cape Town, South Africa: A short report | 1.0 | 8 | Citations (PDF) |
| 38 | Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort | 2.9 | 28 | Citations (PDF) |
| 39 | Optimising influenza vaccination during a SARS-CoV-2 epidemic in South Africa could help maintain the integrity of our healthcare system | 0.7 | 2 | Citations (PDF) |
| 40 | Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study | 2.8 | 20 | Citations (PDF) |
| 41 | Prevalence and risks of hepatitis E virus infection in blood donors from the Western Cape, South Africa | 1.1 | 16 | Citations (PDF) |
| 42 | High positive HIV serology results can still be false positive | 0.8 | 13 | Citations (PDF) |
| 43 | COVID-19: Getting ahead of the epidemic curve by early implementation of social distancing | 0.7 | 28 | Citations (PDF) |
| 44 | Viral hepatitis B and C in HIV-exposed South African infants | 1.9 | 3 | Citations (PDF) |
| 45 | Diagnosis of COVID-19: Considerations, Controversies and Challenges in South Africa | 0.2 | 12 | Citations (PDF) |
| 46 | Pooled testing: A tool to increase efficiency of infant HIV diagnosis and virological monitoring | 0.7 | 5 | Citations (PDF) |
| 47 | Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update | 1.2 | 46 | Citations (PDF) |
| 48 | Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control | 0.0 | 52 | Citations (PDF) |
| 49 | Academic publishing in pandemic times | 1.0 | 1 | Citations (PDF) |
| 50 | Lessons in diagnostic virology: expected and unexpected sources of error | 7.0 | 28 | Citations (PDF) |
| 51 | Pooled PCR testing of dried blood spots for infant HIV diagnosis is cost efficient and accurate | 2.8 | 9 | Citations (PDF) |
| 52 | Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study | 5.4 | 15 | Citations (PDF) |
| 53 | Attempted molecular detection of the thermally dimorphic human fungal pathogen Emergomyces africanus in terrestrial small mammals in South Africa | 0.6 | 18 | Citations (PDF) |
| 54 | HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa | 2.8 | 24 | Citations (PDF) |
| 55 | HIV-1 RNA testing of pooled dried blood spots is feasible to diagnose acute HIV infection in resource limited settings | 0.4 | 1 | Citations (PDF) |
| 56 | HIV-1 RNA testing of pooled dried blood spots is feasible to diagnose acute HIV infection in resource limited settings | 0.4 | 0 | Citations (PDF) |
| 57 | Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype? | 2.0 | 15 | Citations (PDF) |
| 58 | Interpretation of indeterminate HIV-1 PCR results are influenced by changing vertical transmission prevention regimens | 3.1 | 6 | Citations (PDF) |
| 59 | Moderate levels of preantiretroviral therapy drug resistance in a generalized epidemicAids, 2017, 31, 2387-2391 | 2.5 | 7 | Citations (PDF) |
| 60 | Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience | 2.4 | 45 | Citations (PDF) |
| 61 | Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial | 2.4 | 21 | Citations (PDF) |
| 62 | Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa | 1.5 | 15 | Citations (PDF) |
| 63 | Novel Arenavirus Isolates from Namaqua Rock Mice, Namibia, Southern Africa | 3.9 | 11 | Citations (PDF) |
| 64 | The HIV/HBV co-infected patient: Time for proactive management | 0.7 | 4 | Citations (PDF) |
| 65 | Hepatitis E virus infection: An underdiagnosed infection in transplant patients in Southern Africa? | 3.1 | 12 | Citations (PDF) |
| 66 | Evolutionary origins of hepatitis A virus in small mammals | 7.6 | 124 | Citations (PDF) |
| 67 | Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa | 3.2 | 24 | Citations (PDF) |
| 68 | Altered Innate Immune Development in HIV-Exposed Uninfected Infants | 1.8 | 77 | Citations (PDF) |
| 69 | Hantaviruses in Africa | 2.6 | 51 | Citations (PDF) |
| 70 | Irreproducible positive results on the Cobas AmpliPrep/Cobas TaqMan HIV‐1 Qual test are different qualitatively from confirmed positive results | 3.8 | 19 | Citations (PDF) |
| 71 | Rooting the Phylogenetic Tree of Middle East Respiratory Syndrome Coronavirus by Characterization of a Conspecific Virus from an African Bat | 3.7 | 369 | Citations (PDF) |
| 72 | A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy | 3.1 | 9 | Citations (PDF) |
| 73 | The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa | 3.2 | 65 | Citations (PDF) |
| 74 | Pooled HIV-1 Viral Load Testing Using Dried Blood Spots to Reduce the Cost of Monitoring Antiretroviral Treatment in a Resource-Limited Setting | 1.8 | 24 | Citations (PDF) |
| 75 | Close Relative of Human Middle East Respiratory Syndrome Coronavirus in Bat, South Africa | 3.9 | 347 | Citations (PDF) |
| 76 | Antibody Responses to Vaccination among South African HIV-Exposed and Unexposed Uninfected Infants during the First 2 Years of Life | 3.0 | 78 | Citations (PDF) |
| 77 | Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens | 2.4 | 63 | Citations (PDF) |
| 78 | Construction of a High Titer Infectious HIV-1 Subtype C Proviral Clone from South Africa | 3.3 | 2 | Citations (PDF) |
| 79 | High HBV Viral Loads in HIV-Infected Pregnant Women at a Tertiary Hospital, South Africa | 1.8 | 19 | Citations (PDF) |
| 80 | Establishing diagnostic cut-off criteria for the COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative test through validation against the Amplicor DNA test v1.5 for infant diagnosis using dried blood spots | 3.1 | 31 | Citations (PDF) |
| 81 | Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of South African Infants throughout the First Year of Life | 2.4 | 36 | Citations (PDF) |
| 82 | HIV Drug Resistance (HIVDR) in Antiretroviral Therapy-Naïve Patients in Tanzania Not Eligible for WHO Threshold HIVDR Survey Is Dramatically High | 2.4 | 46 | Citations (PDF) |
| 83 | Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI‐based regimens in the western cape, South Africa | 3.8 | 35 | Citations (PDF) |
| 84 | Optimising automation of a manual enzyme-linked immunosorbent assay | 0.7 | 1 | Citations (PDF) |
| 85 | Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited Setting | 5.4 | 56 | Citations (PDF) |
| 86 | HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving Concepts | 1.0 | 236 | Citations (PDF) |
| 87 | Significantly Diminished Long-Term Specificity of the BED Capture Enzyme Immunoassay Among Patients With HIV-1 With Very Low CD4 Counts and Those on Antiretroviral Therapy | 1.8 | 64 | Citations (PDF) |
| 88 | NucliSens EasyQ® HIV-1 V1.2 system: Detection of human plasma-derived background signal | 1.7 | 5 | Citations (PDF) |
| 89 | Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIV | 3.8 | 4 | Citations (PDF) |
| 90 | Klinik, Epidemiologie und Diagnostik tropischer Virusinfektionen. Tropische Viren nicht nur in den Tropen | 0.0 | 4 | Citations (PDF) |
| 91 | Pandemic influenza A (H1N1) 2009: the experience of the first six months | 2.4 | 15 | Citations (PDF) |
| 92 | Prevalence- and Gender-Specific Immune Response to Opportunistic Infections in HIV-Infected Patients in Lesotho | 1.3 | 21 | Citations (PDF) |
| 93 | Extraction buffer contaminated bacterially as a cause of invalid HIV-1 viral load results on the NucliSens EasyQ® system | 1.7 | 5 | Citations (PDF) |
| 94 | Reconstitution of Cytomegalovirus Specific T Cells after Pediatric Allogeneic Stem Cell Transplantation: Results from a Pilot Study Using a Multi-Allele CMV Tetramer Group | 0.6 | 12 | Citations (PDF) |
| 95 | Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation | 3.1 | 8 | Citations (PDF) |
| 96 | Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa | 3.1 | 31 | Citations (PDF) |
| 97 | Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants | 8.5 | 656 | Citations (PDF) |
| 98 | Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5′ Long Terminal Repeat Domain | 1.1 | 93 | Citations (PDF) |
| 99 | Anti‐HIV, Anti‐Poxvirus, and Anti‐SARS Activity of a Nontoxic, Acidic Plant Extract from the <i>Trifollium</i> Species Secomet‐V/anti‐Vac Suggests That It Contains a Novel Broad‐Spectrum Antiviral | 4.1 | 39 | Citations (PDF) |
| 100 | Development of antiviral therapy for severe acute respiratory syndrome | 3.8 | 64 | Citations (PDF) |
| 101 | Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) and TruGene (Bayer) | 0.0 | 0 | Citations (PDF) |
| 102 | Comparative evaluation of the Cobas Amplicor HIV-1 Monitor™ Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor™ Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples | 3.1 | 32 | Citations (PDF) |
| 103 | HBV reactivation after kidney transplantation | 3.1 | 63 | Citations (PDF) |
| 104 | Neue Methoden in der Zytomegalievirus-Diagnostik | 0.2 | 1 | Citations (PDF) |
| 105 | Activation of the Cytokine Network and Unfavorable Outcome in Patients with Yellow Fever | 3.8 | 100 | Citations (PDF) |
| 106 | Das SARS-assoziierte Coronavirus – Die erste Pandemie des 21. Jahrhunderts / The SARS-associated coronavirus – The first pandemic of the 21st century | 0.2 | 0 | Citations (PDF) |
| 107 | Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus | 4.1 | 100 | Citations (PDF) |
| 108 | NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions | 0.8 | 25 | Citations (PDF) |
| 109 | Severe acute respiratory syndrome (SARS)—paradigm of an emerging viral infection | 3.1 | 111 | Citations (PDF) |
| 110 | Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets | 52.8 | 259 | Citations (PDF) |
| 111 | Stability and inactivation of SARS coronavirus | 3.0 | 499 | Citations (PDF) |
| 112 | Primary Cytomegalovirus Infection in
an Outpatient Setting—Laboratory Markers and Clinical
Aspects | 3.2 | 48 | Citations (PDF) |
| 113 | Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma | 3.1 | 24 | Citations (PDF) |
| 114 | Severe acute respiratory syndrome: identification of the etiological agent | 7.7 | 100 | Citations (PDF) |
| 115 | Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome | 43.7 | 4,208 | Citations (PDF) |
| 116 | Klinik und Behandlung des
schweren akuten respiratorischen Syndroms | 0.2 | 11 | Citations (PDF) |
| 117 | Role of China in the Quest To Define and Control Severe Acute Respiratory Syndrome | 3.9 | 54 | Citations (PDF) |
| 118 | Variety of Interpretation Systems for Human Immunodeficiency Virus Type 1 Genotyping: Confirmatory Information or Additional Confusion? | 2.2 | 26 | Citations (PDF) |
| 119 | Chemotherapeutika-Resistenz und neue Virusvarianten bei sexuell übertragbaren Infektionen/Chemotherapeutic Resistance and Novel Virus Variants in Sexually Transmitted Infections | 0.2 | 0 | Citations (PDF) |
| 120 | Quantifizierung von CMV-DNA als diagnostisches Werkzeug zur verbesserten Behandlung und berwachung von Risikopatienten/CMV Genome Quantification as a Diagnostic Tool for Improving Treatment and Monitoring of Risk Patients | 0.2 | 0 | Citations (PDF) |
| 121 | HHV-8 Seroprävalenz in ausgewählten (Risiko)-Kollektiven im Raum Frankfurt am Main/HHV-8 Seroprevalence in Selected (Risk)-Groups in the Area of Frankfurt am Main | 0.2 | 0 | Citations (PDF) |
| 122 | Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV | 3.2 | 33 | Citations (PDF) |
| 123 | Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor™ Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor™ test (manual specimen preparation) | 3.1 | 25 | Citations (PDF) |
| 124 | Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma | 1.7 | 15 | Citations (PDF) |
| 125 | Virology and epidemiology of oral herpesvirus infections | 3.0 | 2 | Citations (PDF) |
| 126 | The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection | 3.1 | 50 | Citations (PDF) |
| 127 | Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants | 3.1 | 69 | Citations (PDF) |
| 128 | Enterovirus Infections in Germany: Comparative Evaluation of Different Laboratory Diagnostic Methods | 3.2 | 15 | Citations (PDF) |
| 129 | False-negative HIV antibody test results 2000, 60, 43-47 | | 16 | Citations (PDF) |
| 130 | Cytomegalovirus Infection Decreases Expression of Thrombospondin‐1 and ‐2 in Cultured Human Retinal Glial Cells: Effects of Antiviral Agents | 3.8 | 27 | Citations (PDF) |
| 131 | No apparent effect of cidofovir in epidermodysplasia verruciformis | 3.1 | 19 | Citations (PDF) |
| 132 | Übertragbare spongiforme Encephalopathien: die Creutzfeldt-Jakob-Krankheit | 0.6 | 0 | Citations (PDF) |
| 133 | Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil | 52.8 | 698 | Citations (PDF) |
| 134 | Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus | 1.7 | 33 | Citations (PDF) |
| 135 | Lack of correlation between different hepatitis C virus screening and confirmatory assays | 1.7 | 9 | Citations (PDF) |
| 136 | Unusual course of herpes simplex virus encephalitis after acyclovir therapy | 3.2 | 17 | Citations (PDF) |
| 137 | Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment | 1.4 | 47 | Citations (PDF) |
| 138 | Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays | 1.7 | 21 | Citations (PDF) |
